Logo image of KIN2.DE

KINROSS GOLD CORP (KIN2.DE) Stock Fundamental Analysis

Europe - FRA:KIN2 - CA4969024047 - Common Stock

19.27 EUR
-0.54 (-2.73%)
Last: 9/16/2025, 7:00:00 PM
Fundamental Rating

6

KIN2 gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 38 industry peers in the Metals & Mining industry. KIN2 gets an excellent profitability rating and is at the same time showing great financial health properties. KIN2 has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year KIN2 was profitable.
KIN2 had a positive operating cash flow in the past year.
Of the past 5 years KIN2 4 years were profitable.
In the past 5 years KIN2 always reported a positive cash flow from operatings.
KIN2.DE Yearly Net Income VS EBIT VS OCF VS FCFKIN2.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

1.2 Ratios

With an excellent Return On Assets value of 14.08%, KIN2 belongs to the best of the industry, outperforming 94.74% of the companies in the same industry.
KIN2's Return On Equity of 22.29% is amongst the best of the industry. KIN2 outperforms 94.74% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.87%, KIN2 belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for KIN2 is in line with the industry average of 8.13%.
The 3 year average ROIC (6.23%) for KIN2 is below the current ROIC(14.87%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 14.08%
ROE 22.29%
ROIC 14.87%
ROA(3y)2.29%
ROA(5y)4.25%
ROE(3y)3.43%
ROE(5y)6.8%
ROIC(3y)6.23%
ROIC(5y)6.54%
KIN2.DE Yearly ROA, ROE, ROICKIN2.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

KIN2 has a Profit Margin of 25.18%. This is amongst the best in the industry. KIN2 outperforms 92.11% of its industry peers.
In the last couple of years the Profit Margin of KIN2 has declined.
KIN2 has a better Operating Margin (38.20%) than 89.47% of its industry peers.
KIN2's Operating Margin has improved in the last couple of years.
KIN2 has a Gross Margin of 44.10%. This is in the better half of the industry: KIN2 outperforms 71.05% of its industry peers.
KIN2's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 38.2%
PM (TTM) 25.18%
GM 44.1%
OM growth 3Y9.12%
OM growth 5Y8.75%
PM growth 3Y45.92%
PM growth 5Y-2.15%
GM growth 3Y3.98%
GM growth 5Y4.42%
KIN2.DE Yearly Profit, Operating, Gross MarginsKIN2.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

8

2. Health

2.1 Basic Checks

KIN2 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
KIN2 has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, KIN2 has less shares outstanding
KIN2 has a better debt/assets ratio than last year.
KIN2.DE Yearly Shares OutstandingKIN2.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
KIN2.DE Yearly Total Debt VS Total AssetsKIN2.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 4.58 indicates that KIN2 is not in any danger for bankruptcy at the moment.
KIN2 has a better Altman-Z score (4.58) than 86.84% of its industry peers.
The Debt to FCF ratio of KIN2 is 0.72, which is an excellent value as it means it would take KIN2, only 0.72 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.72, KIN2 belongs to the best of the industry, outperforming 97.37% of the companies in the same industry.
KIN2 has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
KIN2 has a better Debt to Equity ratio (0.18) than 71.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.72
Altman-Z 4.58
ROIC/WACC1.68
WACC8.85%
KIN2.DE Yearly LT Debt VS Equity VS FCFKIN2.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.01 indicates that KIN2 has no problem at all paying its short term obligations.
KIN2 has a Current ratio (2.01) which is in line with its industry peers.
KIN2 has a Quick Ratio of 2.01. This is a bad value and indicates that KIN2 is not financially healthy enough and could expect problems in meeting its short term obligations.
KIN2's Quick ratio of 0.83 is on the low side compared to the rest of the industry. KIN2 is outperformed by 68.42% of its industry peers.
KIN2 does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 0.83
KIN2.DE Yearly Current Assets VS Current LiabilitesKIN2.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

KIN2 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 151.06%, which is quite impressive.
Measured over the past years, KIN2 shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.87% on average per year.
The Revenue has grown by 34.40% in the past year. This is a very strong growth!
Measured over the past years, KIN2 shows a quite strong growth in Revenue. The Revenue has been growing by 8.04% on average per year.
EPS 1Y (TTM)151.06%
EPS 3Y17.42%
EPS 5Y14.87%
EPS Q2Q%214.29%
Revenue 1Y (TTM)34.4%
Revenue growth 3Y11.35%
Revenue growth 5Y8.04%
Sales Q2Q%41.74%

3.2 Future

Based on estimates for the next years, KIN2 will show a decrease in Earnings Per Share. The EPS will decrease by -8.40% on average per year.
Based on estimates for the next years, KIN2 will show a decrease in Revenue. The Revenue will decrease by -4.86% on average per year.
EPS Next Y116.29%
EPS Next 2Y49.24%
EPS Next 3Y28.3%
EPS Next 5Y-8.4%
Revenue Next Year28.96%
Revenue Next 2Y15.87%
Revenue Next 3Y8.45%
Revenue Next 5Y-4.86%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
KIN2.DE Yearly Revenue VS EstimatesKIN2.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
KIN2.DE Yearly EPS VS EstimatesKIN2.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1 1.5

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 19.27, KIN2 is valued on the expensive side.
Based on the Price/Earnings ratio, KIN2 is valued a bit cheaper than the industry average as 60.53% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.20, KIN2 is valued a bit cheaper.
The Price/Forward Earnings ratio is 15.02, which indicates a correct valuation of KIN2.
KIN2's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.70. KIN2 is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.27
Fwd PE 15.02
KIN2.DE Price Earnings VS Forward Price EarningsKIN2.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as KIN2.
84.21% of the companies in the same industry are more expensive than KIN2, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.32
EV/EBITDA 8.47
KIN2.DE Per share dataKIN2.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

KIN2's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KIN2 has an outstanding profitability rating, which may justify a higher PE ratio.
KIN2's earnings are expected to grow with 28.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.17
PEG (5Y)1.3
EPS Next 2Y49.24%
EPS Next 3Y28.3%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.51%, KIN2 is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.77, KIN2 is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.38, KIN2's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.51%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
KIN2.DE Yearly Dividends per shareKIN2.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 0.05 0.1 0.15

5.3 Sustainability

KIN2 pays out 9.64% of its income as dividend. This is a sustainable payout ratio.
DP9.64%
EPS Next 2Y49.24%
EPS Next 3Y28.3%
KIN2.DE Yearly Income VS Free CF VS DividendKIN2.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B
KIN2.DE Dividend Payout.KIN2.DE Dividend Payout, showing the Payout Ratio.KIN2.DE Dividend Payout.PayoutRetained Earnings

KINROSS GOLD CORP

FRA:KIN2 (9/16/2025, 7:00:00 PM)

19.27

-0.54 (-2.73%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)11-04 2025-11-04
Inst Owners68.33%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap24.06B
Analysts80
Price Target18.31 (-4.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.51%
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP9.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)37.38%
Min EPS beat(2)28.59%
Max EPS beat(2)46.17%
EPS beat(4)3
Avg EPS beat(4)20.46%
Min EPS beat(4)-18.81%
Max EPS beat(4)46.17%
EPS beat(8)7
Avg EPS beat(8)21.33%
EPS beat(12)10
Avg EPS beat(12)25.78%
EPS beat(16)12
Avg EPS beat(16)18.03%
Revenue beat(2)2
Avg Revenue beat(2)51455.9%
Min Revenue beat(2)20.12%
Max Revenue beat(2)102892%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.18%
PT rev (3m)11.35%
EPS NQ rev (1m)0.47%
EPS NQ rev (3m)65.09%
EPS NY rev (1m)53.71%
EPS NY rev (3m)53.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)6.8%
Revenue NY rev (3m)10.75%
Valuation
Industry RankSector Rank
PE 19.27
Fwd PE 15.02
P/S 4.68
P/FCF 14.32
P/OCF 9.29
P/B 4.14
P/tB 4.14
EV/EBITDA 8.47
EPS(TTM)1
EY5.19%
EPS(NY)1.28
Fwd EY6.66%
FCF(TTM)1.35
FCFY6.98%
OCF(TTM)2.07
OCFY10.76%
SpS4.12
BVpS4.65
TBVpS4.65
PEG (NY)0.17
PEG (5Y)1.3
Profitability
Industry RankSector Rank
ROA 14.08%
ROE 22.29%
ROCE 23.66%
ROIC 14.87%
ROICexc 15.86%
ROICexgc 15.86%
OM 38.2%
PM (TTM) 25.18%
GM 44.1%
FCFM 32.67%
ROA(3y)2.29%
ROA(5y)4.25%
ROE(3y)3.43%
ROE(5y)6.8%
ROIC(3y)6.23%
ROIC(5y)6.54%
ROICexc(3y)6.62%
ROICexc(5y)7.08%
ROICexgc(3y)6.62%
ROICexgc(5y)7.14%
ROCE(3y)9.92%
ROCE(5y)10.4%
ROICexcg growth 3Y20.62%
ROICexcg growth 5Y13.48%
ROICexc growth 3Y21.33%
ROICexc growth 5Y13.94%
OM growth 3Y9.12%
OM growth 5Y8.75%
PM growth 3Y45.92%
PM growth 5Y-2.15%
GM growth 3Y3.98%
GM growth 5Y4.42%
F-Score7
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.72
Debt/EBITDA 0.36
Cap/Depr 94.78%
Cap/Sales 17.67%
Interest Coverage 24.34
Cash Conversion 88.57%
Profit Quality 129.73%
Current Ratio 2.01
Quick Ratio 0.83
Altman-Z 4.58
F-Score7
WACC8.85%
ROIC/WACC1.68
Cap/Depr(3y)100.83%
Cap/Depr(5y)104.58%
Cap/Sales(3y)22.97%
Cap/Sales(5y)23.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)151.06%
EPS 3Y17.42%
EPS 5Y14.87%
EPS Q2Q%214.29%
EPS Next Y116.29%
EPS Next 2Y49.24%
EPS Next 3Y28.3%
EPS Next 5Y-8.4%
Revenue 1Y (TTM)34.4%
Revenue growth 3Y11.35%
Revenue growth 5Y8.04%
Sales Q2Q%41.74%
Revenue Next Year28.96%
Revenue Next 2Y15.87%
Revenue Next 3Y8.45%
Revenue Next 5Y-4.86%
EBIT growth 1Y144.17%
EBIT growth 3Y21.5%
EBIT growth 5Y17.5%
EBIT Next Year131.51%
EBIT Next 3Y30.48%
EBIT Next 5Y1.99%
FCF growth 1Y356.37%
FCF growth 3Y91.05%
FCF growth 5Y62.85%
OCF growth 1Y110.57%
OCF growth 3Y29.17%
OCF growth 5Y14.84%